|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
33
|
|
pubmed:dateCreated |
2009-11-20
|
|
pubmed:abstractText |
To explore a more effective treatment for localized nasal natural killer (NK)/T-cell lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:HottaTomomitsuT,
pubmed-author:IshikuraSatoshiS,
pubmed-author:IshizawaKenichiK,
pubmed-author:IshizukaNaokiN,
pubmed-author:IsobeYasushiY,
pubmed-author:ItohKuniakiK,
pubmed-author:KagamiYoshikazuY,
pubmed-author:KinoshitaTomohiroT,
pubmed-author:KobayashiYukioY,
pubmed-author:MasekiNobuoN,
pubmed-author:MatsunoYoshihiroY,
pubmed-author:NawanoShigeruS,
pubmed-author:OguchiMasahikoM,
pubmed-author:OhshimaKoichiK,
pubmed-author:OshimiKazuoK,
pubmed-author:TerauchiTakashiT,
pubmed-author:TobinaiKenseiK,
pubmed-author:UsuiNorikoN,
pubmed-author:WasadaIzumiI,
pubmed-author:YamaguchiMotokoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5594-600
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19805668-Adult,
pubmed-meshheading:19805668-Age Factors,
pubmed-meshheading:19805668-Aged,
pubmed-meshheading:19805668-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19805668-Biopsy, Needle,
pubmed-meshheading:19805668-Carboplatin,
pubmed-meshheading:19805668-Combined Modality Therapy,
pubmed-meshheading:19805668-Dexamethasone,
pubmed-meshheading:19805668-Disease-Free Survival,
pubmed-meshheading:19805668-Dose-Response Relationship, Drug,
pubmed-meshheading:19805668-Drug Administration Schedule,
pubmed-meshheading:19805668-Etoposide,
pubmed-meshheading:19805668-Female,
pubmed-meshheading:19805668-Humans,
pubmed-meshheading:19805668-Ifosfamide,
pubmed-meshheading:19805668-Immunohistochemistry,
pubmed-meshheading:19805668-Japan,
pubmed-meshheading:19805668-Kaplan-Meier Estimate,
pubmed-meshheading:19805668-Lymphoma, Extranodal NK-T-Cell,
pubmed-meshheading:19805668-Male,
pubmed-meshheading:19805668-Maximum Tolerated Dose,
pubmed-meshheading:19805668-Middle Aged,
pubmed-meshheading:19805668-Neoplasm Staging,
pubmed-meshheading:19805668-Nose Neoplasms,
pubmed-meshheading:19805668-Probability,
pubmed-meshheading:19805668-Proportional Hazards Models,
pubmed-meshheading:19805668-Radiotherapy, Adjuvant,
pubmed-meshheading:19805668-Radiotherapy, Conformal,
pubmed-meshheading:19805668-Radiotherapy Dosage,
pubmed-meshheading:19805668-Risk Assessment,
pubmed-meshheading:19805668-Sex Factors,
pubmed-meshheading:19805668-Survival Analysis,
pubmed-meshheading:19805668-Treatment Outcome,
pubmed-meshheading:19805668-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
|
|
pubmed:affiliation |
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. myamaguchi@clin.medic.mie-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
